
Shuttle Pharmaceuticals Issues Warrants for 6.7 Million Shares After Milestones
The pre-funded warrants carry a $0.001 exercise price and were issued for no additional cash, as the company had $90 thousand in cash on June 30, 2026.
Shuttle Pharmaceuticals Holdings, Inc. · Nasdaq · Pharmaceutical Preparations

The pre-funded warrants carry a $0.001 exercise price and were issued for no additional cash, as the company had $90 thousand in cash on June 30, 2026.
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Entry into a material definitive agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings issues 6,693,740 milestone pre-funded warrants at $0.001 exercise price, adding dilution against ~4.8M shares outstanding
Change in certifying accountant · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings Replaces Forvis Mazars with Bush & Associates CPA as Auditor Effective November 2, 2026
Change in certifying accountant · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings dismisses auditor Forvis Mazars amid material weaknesses and no replacement engaged
Financial statements and exhibits
Unregistered sales of equity securities · Financial statements and exhibits
Submission of matters to a vote of security holders · Financial statements and exhibits
Other events · Financial statements and exhibits